Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07456696 · ClinicalTrials.gov registry record · Phase 3
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)
A Phase 3 study of Post Traumatic Stress Disorder, sponsored by Transcend Therapeutics.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 300
- Enrollment target
- 3
- Study locations
NCT07456696 is a Phase 3 study of Post Traumatic Stress Disorder that is actively recruiting participants, run by Transcend Therapeutics. The registered enrollment target is 300 participants, below the 1,115-participant average among 144 other Post Traumatic Stress Disorder trials with a reported enrollment target (73% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT07456696, a Phase 3 study of Post Traumatic Stress Disorder, is actively recruiting participants, sponsored by Transcend Therapeutics.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 300 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study is evaluating the safety and efficacy of TSND-201 in adults with PTSD. Eligible participants will enter a 4-week Treatment Period where they will be randomized 1:1:1 to receive one of two doses of TSND-201 or placebo, once per week. Following the Treatment Period, participants will enter an 8-week Follow-up Period.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG TSND-201
Study Locations (3)
Florida
- CNS Healthcare - Jacksonville
- CNS Healthcare - Orlando
Arkansas
- Preferred Research Partners - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2026-03 |
| Est. Completion | 2027-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07456696
The ClinicalTrials.gov registry entry for NCT07456696 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,115-participant average among 144 other Post Traumatic Stress Disorder trials with a reported enrollment target (73% lower). The listed sponsor is Transcend Therapeutics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT07456696 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Florida, Arkansas.
Frequently Asked Questions
What is clinical trial NCT07456696 about?
NCT07456696 is a clinical study titled "An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)". This study is evaluating the safety and efficacy of TSND-201 in adults with PTSD. Eligible participants will enter a 4-week Treatment Period where they will be randomized 1:1:1 to receive one of two doses of TSND-201 or placebo, once per week. Following the Treatment Period, participants will enter...
What is the current status of trial NCT07456696?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 300 participants. The study started on 2026-03. Estimated completion is 2027-12.
What conditions does trial NCT07456696 study?
This clinical trial studies the following conditions: Post Traumatic Stress Disorder.
What interventions are being tested in trial NCT07456696?
The interventions under investigation include: Placebo (DRUG), TSND-201 (DRUG).
Who is sponsoring clinical trial NCT07456696?
This trial is sponsored by Transcend Therapeutics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07456696 being conducted?
This trial has 3 study locations across Arkansas, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Traumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Goal-Directed Sedation in Mechanically Ventilated Infants and Children
RECRUITING · Phase 3
-
MDMA-assisted Massed Prolonged Exposure for PTSD
RECRUITING · Phase 3
-
Frontline Clinician Psilocybin Study
COMPLETED · Phase 3
-
Maximizing Treatment Outcome and Examining Sleep in Post-traumatic Stress Disorder (PTSD)
COMPLETED · Phase 3
-
Comparison of Videoconference and Face-to-Face Delivery of Cognitive Processing Therapy for Posttraumatic Stress Disorder
COMPLETED · Phase 3
-
Maximizing Treatment Outcome in Post-Traumatic Stress Disorder (PTSD)
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.